Pacira Pharmaceuticals reported $64.65M in Stock for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acelrx Pharmaceuticals ACRX:US $ 1.42M 0.21M
Adamas Pharmaceuticals ADMS:US 7.54M 242K
Aerie Pharmaceuticals AERI:US $ 28.32M 1.26M
Amerisourcebergen ABC:US $ 12954.68M 224.28M
Antares Pharma ATRS:US $ 19.61M 1.4M
Astellas Pharma 4503:JP Y 164080M 8337M
Biodelivery Sciences International BDSI:US $ 16.97M 0.48M
Bristol Myers Squibb BMY:US $ 1953M 121M
Endo International Ordinary Shares ENDP:US $ 362.18M 9.92M
Flexion Therapeutics FLXN:US $ 12.68M 2.72M
Heron Therapeutics HRTX:US $ 42.63M 0.72M
Horizon Pharma HZNP:US $ 238.31M 163.02M
JAZZ PHA JAZZ:US $ 115.48M 20.08M
Johnson & Johnson JNJ:US $ 9952M 608M
Lannett LCI:US $ 113.07M 9.13M
Ligand Pharmaceuticals LGND:US $ 36.93M 10.44M
Omeros OMER:US $ 1.19M 164K
Perrigo Ordinary Shares PRGO:US $ 1136.1M 64.1M
Revance Therapeutics RVNC:US $ 5.63M 0.25M
Supernus Pharmaceuticals SUPN:US $ 50.23M 1.9M
Teva Pharmaceutical TEVA:IT 4.41B 3M
Xeris Pharmaceuticals Inc XERS:US $ 8.35M 0
Zoetis ZTS:US $ 1700M 72M